Article
The medical use of controlled substances has gained new legitimacy. But physicians' dread of regulatory scrutiny lingers.
Female cancer survivors more likely to face fatigue, depression; key clinical insights from the ACP Internal Medicine Meeting 2025; how Rhode Island plans to save primary care – Morning Medical Update
Ep. 62: Physician financial mistakes with The White Coat Investor
Myomo launches MyoPro 2x, enhancing independence for patients with arm and hand paralysis
Ep. 61: Prior authorization with Heather Bassett, MD
Seven steps to boost cash flow for your health care practice
More study needed or vaccine pushback? FDA lags on ruling for Novavax's COVID-19 booster